A study to assess safety and efficacy of SOT201 in patients with advance/metastatic cancer
SC201 (VICTORIA-01)
Phase 1 other active
Quick answer
A study to assess safety and efficacy of SOT201 in patients with advance/metastatic cancer for advanced/metastatic solid tumors is a Phase 1 program (other) at IO Biotech with 1 ClinicalTrials.gov record(s).
Program details
- Company
- IO Biotech
- Indication
- advanced/metastatic solid tumors
- Phase
- Phase 1
- Modality
- other
- Status
- active